Ecole Doctorale Biologie Santé de Lille : bourses de thèse ouvertes à la mobilité

Ecole Doctorale BIOLOGIE SANTE de Lille
Allocations de Recherche "mobilité" - 2017-2018
sujet de thèse proposé par l'Unité de Recherche :
INSERM U1172 éQ. 04 (directeur : QUESNEL BRUNO)

version française english version

Avant de déposer votre dossier, vous devez vous assurer de remplir les conditions requises et impérativement prendre contact avec le responsable du sujet proposé.

Conditions réglementaires de candidature, pré-requis et procédures (cliquez ici)

Microsystem to analyze and isolate small population of Leukemia cells with physical phenotype
réf. -CAN/2017084
responsable : IDZIOREK THIERRY / COLLARD DOMINIQUE / Co-encadrant : Dominique COLLARD
courriel : thierry.idziorek@inserm.fr / collard@iis.u-tokyo.ac.jp,collard@iis.u-tokyo.ac.jp
description du projet :
Acute myeloid leukemia is a highly heterogeneous disease. Our consortium already demonstrated that persistent leukemia cells are few, sometimes less than few hundreds. These cells are (i) the causative agents of late relapse, (ii) refractory to treatments and (iii) leading to relapsing patients poor survival. Deep sequencing by NGS allows identification of these residual cells but their detection is still technically challenging due to lack of phenotypic markers. There is a critical need to find new ways to detect and purify them to anticipate relapse.
This PhD subject aims to analyze and isolate small subpopulation of leukemic cells through their biomechanical properties using MEMS and microfluidic technologies.
The project will start by performing cell characterization (size, mechanical stiffness, deformability, shape recovery time) to determine a high content physical phenotype of relevant cell types. Measurements will be performed with our MEMS tweezers-based platform. The platform will be improved to reach high throughput cell analysis (up to 100 cell/hour) and determine statistically relevant parameters for discriminating leukemia blasts in a heterogeneous cell population.
In the second phase, a microfluidic device will be designed and processed to identify (count) the blast cells in a cell culture sample. The microfluidic device will stimulate the biomechanical response of a cell by squeezing it in a microchannel. The cell size, deformability or recovery time will be measured by recording electric signals on integrated electrodes in contact with fluid as impedance of a flowing cell alters the measured fluid conductivity. The microfluidic device will be evaluated by detecting and counting blast cells from prepared solutions before using it on actual samples. Evaluations will be carried out with an in-house mouse model of tumor dormancy using the fluorescent-protein-tagged cell lines with the objective of technology/protocol transfer to the clinics.

The PhD will be conduct

mots-clés : MEMS technology, cell biomechanics, Leukemia, biophysical phenotyping and cytometry

compétences souhaitées : Microsystems, electrical engineering, experiment, cell biology